Follow us:

Brier Dudley's blog

Brier Dudley offers a critical look at technology and business issues affecting the Northwest.

Topic: Biotech

You are viewing the most recent posts on this topic.

June 26, 2012 at 3:42 PM

Medical ventures highlighted at Innovation Showcase

I’m at the Technology Alliance’s Innovation Showcase taking place at Intiman Theatre this afternoon. Six companies, mostly developing medical products and services, are being highlighted at the event. The audience includes potential investors and tech industry leaders. First up is Seattle’s Xylemed. Founder Ben Anderson formerly worked at Harborview, where he realized how inefficient whiteboards are…


Comments | More in | Topics: Biotech, Entrepreneurs, Startups

July 13, 2010 at 3:43 PM

Tech Alliance showcases early stage ventures

Five startups are presenting today at the state Technology Alliance’s Innovation Showcase, an event intended to connect more early stage companies with investors.

Half the companies that have presented originated at the University of Washington, probably because the school’s more aware of the program, said Linden Rhoads, the school’s vice provost for commercialization.

Here’s a rundown of their presentations.

Assay Dynamics: An automated medical testing platform with a special card to analyze fluids and run multiple tests simultaneously on the same fluid sample. A key innovation is that the machines automatically calibrate every time they’re used.

“What we’re trying to do is allow physicians to do more and more testing in their office,” founder Kjell Nelson said.


Comments | More in | Topics: Biotech, biotech, Education

July 6, 2007 at 9:46 AM

Time for something completely different

I’ve got to put down the iPhone and head to Tri-Cities to cover this breakthrough: Rearchers at the Pacific Northwest National Laboratory figured out how to use “ultrasonic backscattering” to track the quality of fermenting beer. From a Technology Review story: To employ the team’s system, the brewer would first have to run a controlled experiment…


Comments | More in | Topics: Biotech

May 8, 2007 at 5:10 PM

Leroy Hood, pundit extraordinaire

After spending a little time with computational biology pioneer Leroy Hood Monday, I suggested that he write a few columns the next time I take a vacation. Hood was among the big thinkers who spoke Monday at OVP Venture Partners’ Technology Summit, an annual event the Kirkland venture firm holds for investors and investees. Press wasn’t invited,…


Comments | More in | Topics: Biotech

March 1, 2007 at 12:00 PM

State money on tap for biotech

Biotech entrepreneurs, start your grant applications. The state has begun doling out proceeds of its long-ago settlement with the tobacco industry, hoping to give the local biotech industry a boost. The money is being funneled thorugh the Life Sciences Discovery Fund, which finally began taking applications for its first grants today. It’s providing grants of up…


Comments | More in | Topics: Biotech, Public policy

January 11, 2007 at 4:01 PM

Cougar futurists in Seattle

Washington State University is moving into Husky territory with an interesting series of forward-looking faculty lectures, mostly biotech-related, that it will present in Seattle over the next three months. “The Innovators” series begins Feb 8 with “Achieving Psychological Well-Being: Neurochemistry May Hold the Key,” a talk by Professor Jaak Panksepp.


Comments | More in | Topics: Biotech, Education

October 18, 2006 at 12:27 PM

Charles Xavier’s wheelchair close to reality

The latest amazing neurobionics story: Researchers are developing wheelchairs that can be controlled with brain implants, similar to the way X-Men’s Professor Xavier gets around. Massachusetts-based Cyberkinetics is working on the wheelchairs, but Seattle has a few neurobionic companies making progress. Last week Northstar Neuroscience said trials of its stroke recovery technology are…


Comments | More in | Topics: Biotech

October 11, 2006 at 3:22 PM

Bothell’s Diagnostic Ultrasound changes name

It’s now called Verathon. The name change also reflects a new focus at the 22-year-old medical instrument maker, whose flagship product is the BladderScan device for bladder volume measurement. In January it expanded into the anesthesiology market with the acquisition of Saturn Biomedical Systems, a Vancouver, B.C., manufacturer of the GlideScope video laryngoscope (“for fast, easy…


Comments | More in | Topics: Biotech